The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Alliance A091104: A phase II trial of MK-2206 in patients (pts) with progressive, recurrent/metastatic adenoid cystic carcinoma.
 
Alan Loh Ho
Consulting or Advisory Role - AstraZeneca; Eisai; Novartis
Research Funding - AstraZeneca; Bayer; Genentech/Roche; Lilly; Novartis; Pfizer
 
Nathan R. Foster
No Relationships to Disclose
 
Jeffrey P. Meyers
No Relationships to Disclose
 
Shyamprasad Deraje Vasudeva
No Relationships to Disclose
 
Nora Katabi
Research Funding - Pfizer
 
Cristina R. Antonescu
No Relationships to Disclose
 
David G. Pfister
Consulting or Advisory Role - Boehringer Ingelheim
Research Funding - AstraZeneca; Boehringer Ingelheim; Exelixis; Genentech; Novartis
 
Laura E. Horvath
No Relationships to Disclose
 
Charles Erlichman
No Relationships to Disclose
 
Gary K. Schwartz
Honoraria - AstraZeneca; Boehringer Ingelheim; Novartis
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Novartis
Patents, Royalties, Other Intellectual Property - Patent pending regarding development of PNAs for targeted cancer therapy (new technology)
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Novartis